CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 4.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$5,761,459
+174.2%
1,609,346
+182.6%
0.00%
+100.0%
Q2 2023$2,101,282
+12.9%
569,453
+1.3%
0.00%0.0%
Q1 2023$1,860,955
-1.3%
562,222
+15.7%
0.00%0.0%
Q4 2022$1,885,719
+62.1%
486,010
+1.6%
0.00%
Q3 2022$1,163,000
+22.9%
478,212
+0.1%
0.00%
Q2 2022$946,000
+644.9%
477,573
+589.9%
0.00%
Q1 2022$127,000
+29.6%
69,2270.0%0.00%
Q4 2021$98,000
+3.2%
69,227
+17.5%
0.00%
Q2 2021$95,000
-69.6%
58,927
-66.8%
0.00%
Q1 2021$312,000
+1.6%
177,254
+12.9%
0.00%
Q4 2020$307,000
-11.5%
157,007
+8.3%
0.00%
Q3 2020$347,000
-23.1%
144,930
-5.7%
0.00%
Q2 2020$451,000
-9.6%
153,627
-11.3%
0.00%
Q1 2020$499,000
+9.4%
173,254
+52.2%
0.00%
Q4 2019$456,000
-10.1%
113,8340.0%0.00%
Q3 2019$507,000
+100.4%
113,834
+74.6%
0.00%
Q2 2019$253,000
+52.4%
65,180
+49.2%
0.00%
Q1 2019$166,000
+58.1%
43,7000.0%0.00%
Q4 2018$105,000
-61.4%
43,7000.0%0.00%
Q3 2018$272,000
+70.0%
43,700
+23.4%
0.00%
Q2 2018$160,00035,4000.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$15,520,00013.71%
Stonepine Capital Management, LLC 6,940,000$26,927,20011.33%
Caligan Partners LP 2,676,093$10,383,2418.64%
Altium Capital Management LP 2,870,000$11,135,6005.66%
AWM Investment Company, Inc. 6,015,000$23,338,2003.36%
EAM Investors, LLC 1,749,598$6,788,4401.40%
Perceptive Advisors 11,900,255$46,172,9891.30%
EAM Global Investors LLC 836,323$3,244,9330.84%
Potomac Capital Management, Inc. 120,000$4660.54%
OBERWEIS ASSET MANAGEMENT INC/ 536,900$2,083,1720.44%
View complete list of ADMA BIOLOGICS INC shareholders